Moolec Science (MLEC) Non-Current Assets (2022 - 2025)
Moolec Science (MLEC) reported Non-Current Assets of $173.4 million for Q2 2025, down 66.12% on a YoY basis from $511.6 million in Q2 2024, and up 693.91% sequentially from $21.8 million in Q4 2024.
Moolec Science (MLEC) Non-Current Assets (2022 - 2025) Analysis & Trends
Moolec Science (MLEC) has 4 years of Non-Current Assets data on file, last reported at $173.4 million in Q2 2025.
- For the quarter ending Q2 2025, Non-Current Assets fell 66.12% year-over-year to $173.4 million; the trailing twelve-month figure through Jun 2025 stood at $728.2 million (up 28.2% YoY), and the FY2025 full-year result was $173.4 million, down 66.12% from the prior year.
- Non-Current Assets climbed to $173.4 million in Q2 2025, from $21.8 million in the prior quarter.
- In the past five years, Non-Current Assets ranged from a high of $511.6 million in Q2 2024 to a low of $4.6 million in Q2 2022.
- A 4-year average of $74.3 million and a median of $19.3 million in 2023 frame the typical range for Non-Current Assets.
- Across the five-year window, Non-Current Assets jumped 5095.31% in 2024 and sank 66.12% in 2025, its largest moves.
- Tracing MLEC's Non-Current Assets over 4 years: stood at $12.7 million in 2022, then soared by 39.45% to $17.8 million in 2023, then climbed by 22.88% to $21.8 million in 2024, then jumped by 693.91% to $173.4 million in 2025.
- Business Quant data shows MLEC's Non-Current Assets at $173.4 million in Q2 2025, $21.8 million in Q4 2024, and $21.4 million in Q3 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 21.65 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 5.83 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1.95 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 3.95 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.75 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.66 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 289.41 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.96 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 285.82 Mn |
| 10 | Moolec Science | 5.21 Bn | 5.21 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 173.36 Mn |
| Dec 31, 2024 | 21.84 Mn |
| Sep 30, 2024 | 21.40 Mn |
| Jun 30, 2024 | 511.63 Mn |
| Mar 31, 2024 | 19.34 Mn |
| Dec 31, 2023 | 17.77 Mn |
| Sep 30, 2023 | 19.29 Mn |
| Jun 30, 2023 | 9.85 Mn |
| Mar 31, 2023 | 5.01 Mn |
| Dec 31, 2022 | 12.74 Mn |
| Jun 30, 2022 | 4.61 Mn |